INS and diabetes mellitus: The aim of this study is therefore to compare the use of rapid-acting insulin analogues and human regular insulin in relation to the first occurrence of any diabetes-related complication in a cohort of diabetic patients without macrovascular disease at baseline through the analysis of administrative databases.